CYTOKINETICS INC — Director's Dealing 2022

May 12, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2022-05-10

Reporting Person: WIERENGA WENDALL (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-05-10	Common Stock	A	5000	$0.0	Acquired	12033	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-05-10	Non-Qualified Stock Option (right to buy)	$37.89	A	10000	Acquired	2032-05-10	Common Stock (10000)	Direct

Footnotes

F1: Comprised of restricted stock units that will vest in full and in one installment on 05/10/2023.

F2: Options shall vest and become exercisable in 12 equal monthly installments, the first such installment vesting on 06/10/2022 and the last such installment vesting on 05/10/2023.